WHO ICTRP trial
To assess the body resistance improvement and to evaluate the clinical use and…
CTRI/2020/12/030165 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2020/12/030165 |
|---|---|
| Public title | To assess the body resistance improvement and to evaluate the clinical use and well-being of DailyTabâ?¢Gold immuno booster and DailyTabâ?¢Gold immuno booster (For cardiac, diabetic and neuro conditions) along with standard of care in novel corona virus (COVID-19) patients. |
| Scientific title | A double blind, placebo controlled, three arm, randomized clinical trial to evaluate the immuno boosting activity and to assess the efficacy and safety of the test products DailyTabâ?¢Gold Immuno Booster and DailyTabâ?¢Gold Immuno Booster (cardiac, diabetic and neuro conditions) Mfd. By LIFECARE… |
| Primary sponsor | LIFECARE NEURO PRODUCTS LTD |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | India |
| Conditions | Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere |
| Interventions | Intervention1: DailyTabâ?¢Gold immuno booster along with standard of care: DailyTabâ?¢Gold immuno booster, Oral, One tablet daily after break-fast or lunch for 28 days. Standard of care as per hospital protocol for Covid-19. Intervention2… |
| Registration date | Dec 31, 2020 |
| Target size | 45 |
| Secondary IDs | PHAR/LNPL/COVID19/2020/04, Version 01 dated 26 Nov 2020 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: